A combination of three monoclonal antibodies transiently reduced viremia in people living with HIV-1 and not on antiretroviral therapy, but it did not prevent viral rebound. Further studies are needed to determine if this approach can be optimized.
- Boris Julg
- Kathryn E. Stephenson
- Dan H. Barouch
